Stevanato Group, a leading global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries, announced that it will issue financial results for the fourth quarter and fiscal year 2025 on Wednesday, March 4, 2026, at 6:30 a.m. (ET).
Conference call and webcast
The Company will host a conference call and webcast at 8:30 a.m. (ET) on Wednesday, March 4, 2026, to discuss financial results. During the call, management will refer to a slide presentation which will be available on the morning of the call on the “Financial Results” page under the Company’s Investor Relations section of its website.
Pre-registration
Participants who pre-register will be given a conference passcode and unique PIN to gain immediate access to the call and bypass the live operator. Participants are encourage to pre-register for the conference call using the following link: STVN conference call pre-registration.
Webcast
A live, listen-only webcast of the call will be available at the following link: STVN webcast.
Dial in
Those who are unable to pre-register may dial in by calling:
- Italy: +39 02 802 09 11
- United Kingdom: +44 1 212 818004
- United States: +1 718 705 8796
- United States Toll Free: +1 855 265 6958
Questions during the call
Participants who wish to ask questions during the call should use the HD webphone link.
Replay
The webcast will be archived for three months on the Company’s Investor Relations section of its website.